157 related articles for article (PubMed ID: 36222962)
1. Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PL
Nogara PA; Omage FB; Bolzan GR; Delgado CP; Orian L; Rocha JBT
J Mol Model; 2022 Oct; 28(11):354. PubMed ID: 36222962
[TBL] [Abstract][Full Text] [Related]
2. Fluorine Atoms on C
Chaves OA; Rodrigues-Santos CE; Echevarria Á; Sacramento CQ; Fintelman-Rodrigues N; Temerozo JR; Castro-Faria-Neto HC; Souza TMLE
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142848
[TBL] [Abstract][Full Text] [Related]
3.
Tronco Pauletto PJ; Omage FB; Delgado CP; Nogara PA; Teixeira Rocha JB
Curr Drug Discov Technol; 2023; 20(2):e101022209771. PubMed ID: 36221883
[TBL] [Abstract][Full Text] [Related]
4. Diphenyl Diselenide and SARS-CoV-2:
Omage FB; Madabeni A; Tucci AR; Nogara PA; Bortoli M; Rosa ADS; Neuza Dos Santos Ferreira V; Teixeira Rocha JB; Miranda MD; Orian L
J Chem Inf Model; 2023 Apr; 63(7):2226-2239. PubMed ID: 36952618
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and simulation studies of natural compounds of
Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2.
Yu W; Zhao Y; Ye H; Wu N; Liao Y; Chen N; Li Z; Wan N; Hao H; Yan H; Xiao Y; Lai M
J Med Chem; 2022 Dec; 65(24):16252-16267. PubMed ID: 36503248
[TBL] [Abstract][Full Text] [Related]
7. Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds.
Khanal P; Patil VS; Bhandare VV; Dwivedi PSR; Shastry CS; Patil BM; Gurav SS; Harish DR; Roy S
Comput Biol Med; 2022 Jul; 146():105668. PubMed ID: 35667894
[TBL] [Abstract][Full Text] [Related]
8. Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CL
Saquib Q; Bakheit AH; Ahmed S; Ansari SM; Al-Salem AM; Al-Khedhairy AA
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474509
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of SARS-CoV-2 papain-like protease inhibitors.
Jadhav P; Huang B; Osipiuk J; Zhang X; Tan H; Tesar C; Endres M; Jedrzejczak R; Tan B; Deng X; Joachimiak A; Cai J; Wang J
Eur J Med Chem; 2024 Jan; 264():116011. PubMed ID: 38065031
[TBL] [Abstract][Full Text] [Related]
10. Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PL
Zmudzinski M; Rut W; Olech K; Granda J; Giurg M; Burda-Grabowska M; Kaleta R; Zgarbova M; Kasprzyk R; Zhang L; Sun X; Lv Z; Nayak D; Kesik-Brodacka M; Olsen SK; Weber J; Hilgenfeld R; Jemielity J; Drag M
Sci Rep; 2023 Jun; 13(1):9161. PubMed ID: 37280236
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease.
Kandeel M; Abdelrahman AHM; Oh-Hashi K; Ibrahim A; Venugopala KN; Morsy MA; Ibrahim MAA
J Biomol Struct Dyn; 2021 Sep; 39(14):5129-5136. PubMed ID: 32597315
[TBL] [Abstract][Full Text] [Related]
12. Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS-CoV-2 Papain-Like Protease.
Hu H; Wang Q; Su H; Shao Q; Zhao W; Chen G; Li M; Xu Y
Angew Chem Int Ed Engl; 2022 Dec; 61(52):e202212378. PubMed ID: 36308706
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes.
Lin MH; Moses DC; Hsieh CH; Cheng SC; Chen YH; Sun CY; Chou CY
Antiviral Res; 2018 Feb; 150():155-163. PubMed ID: 29289665
[TBL] [Abstract][Full Text] [Related]
14. Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease.
Li L; Ma L; Hu Y; Li X; Yu M; Shang H; Zou Z
Phytochemistry; 2022 Jan; 193():112984. PubMed ID: 34757253
[TBL] [Abstract][Full Text] [Related]
15. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease.
Brewitz L; Kamps JJAG; Lukacik P; Strain-Damerell C; Zhao Y; Tumber A; Malla TR; Orville AM; Walsh MA; Schofield CJ
ChemMedChem; 2022 May; 17(9):e202200016. PubMed ID: 35085423
[TBL] [Abstract][Full Text] [Related]
17. Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors.
Freire MCLC; Noske GD; Bitencourt NV; Sanches PRS; Santos-Filho NA; Gawriljuk VO; de Souza EP; Nogueira VHR; de Godoy MO; Nakamura AM; Fernandes RS; Godoy AS; Juliano MA; Peres BM; Barbosa CG; Moraes CB; Freitas-Junior LHG; Cilli EM; Guido RVC; Oliva G
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443484
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease.
Wang Q; Chen G; He J; Li J; Xiong M; Su H; Li M; Hu H; Xu Y
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239980
[TBL] [Abstract][Full Text] [Related]
19. Novel nitric oxide donors are coronary vasodilators that also bind to the papain-like protease of SARS-CoV-2.
Schmedtje JF; Ciske F; Muzzarelli KM; Assar Z
Biomed Pharmacother; 2024 Apr; 173():116378. PubMed ID: 38492437
[TBL] [Abstract][Full Text] [Related]
20. Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL
Jade D; Ayyamperumal S; Tallapaneni V; Joghee Nanjan CM; Barge S; Mohan S; Nanjan MJ
Eur J Pharmacol; 2021 Jun; 901():174082. PubMed ID: 33823185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]